This article will focus on the two areas of alcohol injury: first, the gastrointestinal system, primarily liver toxicity and cirrhosis, and second, the human toll in injury, examining injury epidemiology information that estimates alcohol's involvement in trauma. Any pharmacist consulting in any capacity, especially related to gastrointestinal disorders, will need to understand the significant sociological, pathological, pharmacological, and psychological impact of alcohol. Pharmacists providing care, including dispensing many different drugs to patients, should be cognizant of the interacting effects of alcohol and the need to warn patients. Finally, the reader will learn of a case in which a pharmacist was sued for not warning about the use of alcohol with a central nervous system depressant, and the resultant litigation after that lawsuit.
Get full access to this article
View all access options for this article.
References
1.
HeathDB:Alcohol and aggression: A “missing link” in worldwide perspective, in GotheilEDrulyeKASkolodaTEWaxmanHM (eds): Alcohol, Drug Abuse and Aggression. Springfield, IL, Charles C. Thomas, Publisher, 1981.
2.
WallgrenHBarryH (eds): Actions of Alcohol. New York, NY, Elsevier1970.
3.
JaffeJH: Drug addiction and drug abuse, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, sixth ed.New York, NY, MacMillan, 1980, pp 552–553.
4.
SchuckitM: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, second ed.New York, NY, Plenum Press, 1985, pp 35–44.
5.
EllenhornMJBarcelouxDG (eds): Medical Toxicology: Diagnosis and Treatment of Human Poisoning. New York, NY, Elsevier, 1988.
6.
BlumK: Alcohol: The world's most devastating drug, in Handbook of Abusable Drugs. New York, NY, Gardner Press.
7.
ShickJFFreedmanDX: Research in non-narcotic drug abuse, in American Handbook of Psychiatry, second ed, vol Six, chapter 25. New York, NY, Basic Books, Inc, 1975.
8.
U.S. Department of Health and Human Services/Public Health Services: Surveillance and assessment of alcohol-related mortality-United States, 1980. MMVVR34: 161–163, 1985.
9.
GrantBFDufourMCHartfordTC:Epidemiology of alcoholic liver disease. Semin Liver Dis8:12–25, 1988.
10.
LieberCS:Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcoholism15:573–592, 1991.
11.
LundquistFTygstrupNWinklerK:Ethanol metabolism and production of free acetate in the human liver. J Clin Invest41:955–961, 1962.
12.
DiehlAMTietjenTG:Treatment of alcoholic liver disease, in LewisJH (ed): A Pharmacologic Approach to Gastrointestinal Disorders. Baltimore, MD, Williams and Wilkins, 1993.
13.
PequignotGTuynsAJBertaJL:Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol77:113–120, 1978.
14.
LelbachWK:Epidemiology of alcoholic liver disease. Progr Liver Dis5:494–515, 1976.
15.
WatkinsPB:Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin Liver Dis10:235–250, 1990.
16.
SeeffLBCuccheriniBAZimmermanHJ:Acetaminophen hepatotoxicity in alcoholics: A therapeutic misadventure. Ann Intern Med104:399–404, 1986.
17.
CalabreseEJ: Alcohol Interactions with Drugs and Chemicals. Chelsea, MI, Lewis Publishers, 1991.
18.
New York City Summary of Vital Statistics, 1986. City of New York, NY.
LieberCS:The influence of alcohol on nutritional status. Nutr Rev46:241–254, 1988.
22.
LieberCharles S. (ed): Medical Disorders of Alcoholism: Pathogenesis and Treatment. Philadelphia, PA, Saunders, 1982.
23.
DiehlAMYangSQCotePWandGS:Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signaling in regenerating rat liver. Hematology15:1212–1219, 1992.
24.
PequignotGTuynsAJBertaJL:Ascitic cirrhosis in relation to alcohol consumption. Int J Epidemiol7:113–120, 1978.
25.
LelbachWK:Epidemiology of alcoholic liver disease. Progr Liver Dis5:494–515, 1976.
26.
GalambosJ:Natural history of alcoholic hepatitis III: Histologic changes. Gastroenterology63:1026–1035, 1972.
27.
ParesACaballereaJBrugueraM:Histological course of alcoholic hepatitis: Influence of abstinence, sex, and extent of hepatic damage. J Hepatol2:33–42, 1986.
28.
FrezzaMdi PadovaCPozzatoG:High blood alcohol levels in women: The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism. N Engl J Med322:95–99, 1990.
29.
CarithersRLHerlongHFDiehlAM:Methyl-prednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trial. Ann Intern Med110:685–690, 1989.
30.
ImperialeTFMcCulloughAJ:Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med113:299–307, 1990.
31.
RaymondM-JPoynardTRueffB:A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med326:507–512, 1992.
32.
NiquilleMBurnandB:Dental disease among alcoholic individuals: A comparative study of hospitalized patients. J Gen Intern Med8:470–475, 1993.
KingWHTuckerKM:Dental problems of alcoholic and nonalcoholic psychiatric patients. J Stud Alcohol34:1208–1211, 1973.
36.
DunkleyRPCarsonRM:Dental requirements of the hospitalized alcoholic patient. J Am Dent Assoc76:800–803, 1968.
37.
FriedlanderAHSolomonDH:Dental management of the geriatric alcoholic patient. Gerodontics4:23–27, 1988.
38.
FriedlanderAHMillsJDGorelickDA:Alcoholism and dental management. Oral Surg Oral Med Oral Pathol63:42–46, 1987.
39.
ChristenAG:Dentistry and the alcoholic patient. Dent Clin North Am27:341–361, 1983.
40.
National Safety Council, 1986.
41.
DoegeTC:Illness and crashes: Is there a relationship. J Safety Res19:145–150, 1988.
42.
FahyBGSoderstromCA:Alcohol, trauma, and anesthesia, in KirbyRRBrownDL (eds): Problems in Anesthesia, vol 4Philadelphia, PA, Lippincott, 1990.
43.
BederkaJP:Under the Influence of Alcohol. Safety Brief, Triodyne Inc8:9, 1993.
44.
EllenhornMJBarcelouxDG (eds): Medical toxicology: Diagnosis and treatment of human poisoning. New York, NY, Elsevier, 1988.
45.
National Highway Traffic Safety Administration, Washington, DC, 1989.
46.
WrightSJ: Alcohol, drugs, and boating. Alcohol Health and Research World, Summer 1985, pp 28–33.
47.
OrlowskiJP:Adolescent drownings: Swimming, boating, diving, and scuba. Pediatr Ann17:259–263, 1987.
48.
EgstromGHRowleyWNWilsonRR: Alcohol and Diving Performance. National Swimming Pool Foundation, 1986, Washington, DC.
49.
MacArthurJDMooreFD:Epidemiology of burns, the burn-prone patient. JAMA231:xx, 1975.
50.
HowlandJHingsonR:Alcohol as a risk factor for injuries or death due to fires and burns: Review of the literature. Public Health Reports September-October102:475, 1987.
51.
RunyanCWBangdiwalaSILinzerMA:Risk factors for fatal residential fires. N Engl J Med327:859–863, 1992.
52.
PristachCASmithCMPerkinsC:Reliability of the self-administered alcoholism screening test (SAAST) in psychiatric inpatients. J Addictive Dis12:77–88, 1993.
53.
GazianoJMBuringJEBreslowJL:Moderate Alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med329:1829–1834, 1993.
54.
HiattRA:Alcohol, in MicozziMSMoonTE (eds): Macronutrients: Investigating their role in cancer. New York, NY, Marcel Dekker, 1992, pp 245–282.
55.
MeyerFWhiteE:Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol138:225–236, 1993.
56.
IARC monographs on the evaluation of carcinogenic risks to humans: Alcohol drinking. Vol 44. Lyon, France, International Agency for Research on Cancer, 1988.
57.
TatroDS (ed): Drug Interaction Facts, 2nd ed.Philadelphia, PA, Lippincott, 1990.
58.
HartlingSGFaberOKWegmanML:Interaction of ethanol and glipizide in humans. Diabetes Care10:683–686, 1987.
59.
KaterRMHTobonFIberFL:Increased rate of Tolbutamide metabolism in alcoholic patients. JAMA207:363, 1969.
60.
WolfsthalSDWiserTH:Chlorpropamide and an antabuse-like reaction. Ann Intern Med103:158, 1985 (letter).
61.
HaldJJacobsonELarsenV:Sensitizing reaction of antabuse to ethyl alcohol. Acta Pharmacol Toxicol4:285, 1948.
62.
McMahonFG:Disulfiram-like reaction to a cephalosporin. JAMA243:2347, 1980.
63.
McMahonFGNovekRJ:Lack of disulfiram-like reactions with ceftizoxide. J Antimicrobiol Chemother10: 129–133, 1982 (suppl C).
64.
LehmannHEBanTANaltohayanE:Metronidazole in the treatment of the alcoholic. Psychiatry Neurol152:395–401, 1966.
65.
WelageLSBerardiRR:Drug interactions with antiulcer agents: Consideration in the treatment of acid-peptic disease. J Pharm Pract7:177–195, 1994.
66.
FeelyJWoodAJ:Effects of Cimetidine on the elimination and actions of ethanol. JAMA247:2819–2821, 1982.
67.
FinchJEKendallMJMitchardM:An assessment of gastric emptying by breathalyzer. Br J Clin Pharmacol1:233–236, 1974.
68.
WassJAHThornerMOMorrisDV:Long-term treatment of acromegaly with bromocriptine, condensed report. Br Med J1:875–878, 1977.
69.
BorgVWeinholdtT:Bromocriptine in the treatment of the alcohol-withdrawal syndrome. Acta Psychiatr Scand65:101–111, 1982.
70.
219 Ill. App. 3d 931.
71.
134 Ill. 2d R.315.
72.
Docket No. 72908—Agenda 21-May 1992. Corina Frye, Special Adm'r of the Estate of Stephen Fry, Deceased, Appellee v. Medicare-Glaser Corporation, et al., Appellants.
73.
O'DonnellJT:“If you warn, do it right,” judge tells pharmacists. Drug Topics134: No 35–36, February 1992.
74.
Miller v. Rhode Island Hospital, 625 A. 2d 778 (R.I. 1993).
